A Functional Coupling Between Carbon Monoxide and Nitric Oxide Contributes to Increased Vasopressin Neuronal Activity in Heart Failure rats

Endocrinology. 2016 May;157(5):2052-66. doi: 10.1210/en.2015-1958. Epub 2016 Mar 16.

Abstract

Despite the pathophysiological importance of neurohumoral activation in patients with heart failure (HF), the precise underlying mechanisms contributing to elevated vasopressin (VP) activation in HF remains unknown. Carbon monoxide (CO) is a gaseous neurotransmitter in the central nervous system that stimulates VP neuronal firing activity. Recently, we showed that the excitatory effect of CO on VP neurons in the hypothalamic paraventricular nucleus (PVN) was mediated by inhibition of nitric oxide (NO). Given that previous studies showed that VP neuronal activity is enhanced, whereas NO inhibitory signaling is blunted in HF rats, we tested whether an enhanced endogenous CO availability within the PVN contributes to elevated VP neuronal activity and blunted NO signaling in HF rats. We found that both haeme-oxygenase 1 (the CO-synthesizing enzyme) protein and mRNA expression levels were enhanced in the PVN of HF compared with sham rats (∼18% and ∼38%, respectively). We report that in sham rats, bath application of a CO donor (tricarbonyldichlororuthenium dimer) increased the firing activity of identified PVN VP neurons (P < .05), whereas inhibition of endogenous CO production (Tin-protoporphyrin IX [SnPP]) failed to affect neuronal activity. In HF rats, however, SnPP decreased VP activity (P < .05), an effect that was occluded by previous NO synathase blockade NG-nitro-larginine methyl ester. Finally, we found that SnPP increased the mean frequency of γ-aminobutyric acid inhibitory postsynaptic currents in VP neurons in HF (P < .05) but not sham rats. Our results support an enhanced endogenous CO excitatory signaling in VP neurons, which likely contributes to blunted NO and γ-aminobutyric acid inhibitory function in HF rats.

MeSH terms

  • Animals
  • Carbon Monoxide / metabolism*
  • Disease Models, Animal
  • Heart Failure / metabolism*
  • Heart Failure / physiopathology
  • Heme Oxygenase-1 / genetics
  • Heme Oxygenase-1 / metabolism
  • Inhibitory Postsynaptic Potentials / drug effects
  • Male
  • Metalloporphyrins / pharmacology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Nitric Oxide / metabolism*
  • Organometallic Compounds / pharmacology
  • Paraventricular Hypothalamic Nucleus / drug effects
  • Paraventricular Hypothalamic Nucleus / metabolism
  • Protoporphyrins / pharmacology
  • Rats
  • Rats, Wistar
  • Vasopressins / metabolism*

Substances

  • Metalloporphyrins
  • Organometallic Compounds
  • Protoporphyrins
  • tricarbonyldichlororuthenium (II) dimer
  • Vasopressins
  • Nitric Oxide
  • Carbon Monoxide
  • tin protoporphyrin IX
  • Heme Oxygenase-1